Dr. Ahmad continues leading, pioneering work and is the first endocrinologist to publish a study like this — showing the efficacy of non-surgical, outpatient radiofrequency ablation for treating cancer without surgery

We're proud to share that Dr. Shahzad Ahmad's latest research has been published in Clinical Medicine Insights: Endocrinology and Diabetes.

The study looked at radiofrequency ablation (RFA), a minimally invasive, needle-based procedure, as a treatment option for select patients with low-risk papillary thyroid cancer, performed right in the outpatient clinic. For eligible patients, this can mean avoiding surgery altogether while still effectively treating the cancer, with a quicker recovery and no incision.

We're proud to share that Dr. Shahzad Ahmad's latest research, co-authored with Dr. Sean Nikravan, has been accepted for publication in Clinical Medicine Insights: Endocrinology and Diabetes.

The study looks at radiofrequency ablation (RFA), a minimally invasive, needle-based procedure, as a treatment option for select patients with low-risk papillary thyroid cancer, performed right in the outpatient clinic. For eligible patients, this can mean avoiding surgery altogether while still effectively treating the cancer, with a quicker recovery and no incision.

Radiofrequency ablation (RFA) of thyroid nodules is a non-mainstream treatment option for benign thyroid nodules. Studies in Asia and Europe (1) have demonstrated RFA to be an effective outpatient alternative to surgery, however, these results have not been reproduced in North America. Hypothesis: RFA of symptomatic benign thyroid nodules can reduce morbidity associated with thyroidectomies, without sacrificing favorable clinical outcomes.